Efficient expression of concatenated α1β2δ and α1β3δ GABA
DS2
GABA
allopregnanolone
ethanol
etomidate
receptor
stoichiometry
Journal
British journal of pharmacology
ISSN: 1476-5381
Titre abrégé: Br J Pharmacol
Pays: England
ID NLM: 7502536
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
14
10
2020
revised:
28
12
2020
accepted:
11
01
2021
pubmed:
26
1
2021
medline:
6
7
2021
entrez:
25
1
2021
Statut:
ppublish
Résumé
GABA Novel δ-containing pentameric concatenated constructs were designed. The resulting α1β2δ and α1β3δ GABA First, while homogenous α1βδ GABA Our data answer important outstanding questions regarding the pharmacology and stoichiometry of α1δ-containing GABA
Sections du résumé
BACKGROUND AND PURPOSE
GABA
EXPERIMENTAL APPROACH
Novel δ-containing pentameric concatenated constructs were designed. The resulting α1β2δ and α1β3δ GABA
KEY RESULTS
First, while homogenous α1βδ GABA
CONCLUSION AND IMPLICATIONS
Our data answer important outstanding questions regarding the pharmacology and stoichiometry of α1δ-containing GABA
Substances chimiques
Protein Subunits
0
Receptors, GABA-A
0
gamma-Aminobutyric Acid
56-12-2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1556-1573Subventions
Organisme : The Australian National Health & Medical Research Council
ID : APP1185122
Organisme : The Australian National Health & Medical Research Council
ID : APP1124567
Organisme : The Australian Research Council
ID : LP160100560
Informations de copyright
© 2021 The British Pharmacological Society.
Références
Ahring, P. K., Bang, L. H., Jensen, M. L., Strøbaek, D., Hartiadi, L. Y., Chebib, M., & Absalom, N. (2016). A pharmacological assessment of agonists and modulators at α4β2γ2 and α4β2δ GABAA receptors: The challenge in comparing apples with oranges. Pharmacological Research, 111, 563-576. https://doi.org/10.1016/j.phrs.2016.05.014
Ahring, P. K., Liao, V. W. Y., & Balle, T. (2018). Concatenated nicotinic acetylcholine receptors: A gift or a curse? The Journal of General Physiology, 150, 453-473. https://doi.org/10.1085/jgp.201711846
Akk, G., Bracamontes, J., & Steinbach, J. H. (2004). Activation of GABAA receptors containing the α4 subunit by GABA and pentobarbital. The Journal of Physiology, 556, 387-399. https://doi.org/10.1113/jphysiol.2003.058230
Alexander, S. P. H., Mathie, A., Peters, J. A., Veale, E. L., Striessnig, J., Kelly, E., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., & Sharman, J. L. (2019). The Concise Guide to PHARMACOLOGY 2019/20: Ion channels. British Journal of Pharmacology, 176, S142-S228. https://doi.org/10.1111/bph.14749
Anstee, Q. M., Knapp, S., Maguire, E. P., Hosie, A. M., Thomas, P., Mortensen, M., Bhome, R., Martinez, A., Walker, S. E., Dixon, C. I., Ruparelia, K., Montagnese, S., Kuo, Y.-T., Herlihy, A., Bell, J. D., Robinson, I., Guerrini, I., McQuillin, A., Fisher, E. M. C., … Thomas, H. C. (2013). Mutations in the Gabrb1 gene promote alcohol consumption through increased tonic inhibition. Nature Communications, 4, 2816. https://doi.org/10.1038/ncomms3816
Auerbach, A. (2010). The gating isomerization of neuromuscular acetylcholine receptors. The Journal of Physiology, 588, 573-586. https://doi.org/10.1113/jphysiol.2009.182774
Baur, R., Kaur, K. H., & Sigel, E. (2010). Diversity of structure and function of α1α6β3δ GABAA receptors: Comparison with α1β3δ and α6β3δ receptors. The Journal of Biological Chemistry, 285, 17398-17405. https://doi.org/10.1074/jbc.M110.108670
Bianchi, M. T., & Macdonald, R. L. (2003). Neurosteroids shift partial agonist activation of GABAA receptor channels from low- to high-efficacy gating patterns. The Journal of Neuroscience, 23, 10934-10943. https://doi.org/10.1523/JNEUROSCI.23-34-10934.2003
Borghese, C. M., & Harris, R. A. (2007). Studies of ethanol actions on recombinant δ-containing γ-aminobutyric acid type A receptors yield contradictory results. Alcohol, 41, 155-162. https://doi.org/10.1016/j.alcohol.2007.03.006
Borghese, C. M., Stórustovu, S. Í., Ebert, B., Herd, M. B., Belelli, D., Lambert, J. J., Marshall, G., Wafford, K. A., & Harris, R. A. (2006). The δ subunit of γ-aminobutyric acid type A receptors does not confer sensitivity to low concentrations of ethanol. The Journal of Pharmacology and Experimental Therapeutics, 316, 1360-1368. https://doi.org/10.1124/jpet.105.092452
Bowen, M. T., Peters, S. T., Absalom, N., Chebib, M., Neumann, I. D., & McGregor, I. S. (2015). Oxytocin prevents ethanol actions at δ subunit-containing GABAA receptors and attenuates ethanol-induced motor impairment in rats. Proceedings of the National Academy of Sciences of the United States of America, 112, 3104-3109. https://doi.org/10.1073/pnas.1416900112
Brown, N., Kerby, J., Bonnert, T. P., Whiting, P. J., & Wafford, K. A. (2002). Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors. British Journal of Pharmacology, 136, 965-974. https://doi.org/10.1038/sj.bjp.0704795
Curtis, M. J., Ashton, J. C., Moon, L. D. F., & Ahluwalia, A. (2018). Clarification of the basis for the selection of requirements for publication in the British Journal of Pharmacology. British Journal of Pharmacology, 175, 3633-3635. https://doi.org/10.1111/bph.14443
Dascal, N. (2001). Voltage clamp recordings from Xenopus oocytes. Current Protocols in Neuroscience, 10, 6.12.1-6.12.20.
Eaton, M. M., Bracamontes, J., Shu, H. J., Li, P., Mennerick, S., Steinbach, J. H., & Akk, G. (2014). γ-Aminobutyric acid type A α4, β2, and δ subunits assemble to produce more than one functionally distinct receptor type. Molecular Pharmacology, 86, 647-656. https://doi.org/10.1124/mol.114.094813
Feng, H. J., Jounaidi, Y., Haburcak, M., Yang, X., & Forman, S. A. (2014). Etomidate produces similar allosteric modulation in α1β3δ and α1β3γ2L GABAA receptors. British Journal of Pharmacology, 171, 789-798. https://doi.org/10.1111/bph.12507
Fisher, J. L., & Macdonald, R. L. (1997). Single channel properties of recombinant GABAA receptors containing γ2 or δ subtypes expressed with α1 and β3. Journal of Physiology, 505(Pt 2), 283-297. https://doi.org/10.1517/13543784.6.10.1395
Glykys, J., Peng, Z., Chandra, D., Homanics, G. E., Houser, C. R., & Mody, I. (2007). A new naturally occurring GABAA receptor subunit partnership with high sensitivity to ethanol. Nature Neuroscience, 10, 40-48. https://doi.org/10.1038/nn1813
Hammer, H., Bader, B. M., Ehnert, C., Bundgaard, C., Bunch, L., Hoestgaard-Jensen, K., Schroeder, O. H.-U., Bastlund, J. F., Gramowski-Voß, A., & Jensen, A. A. (2015). A multifaceted GABAA receptor modulator: Functional properties and mechanism of action of the sedative-hypnotic and recreational drug methaqualone (Quaalude). Molecular Pharmacology, 88, 401-420. https://doi.org/10.1124/mol.115.099291
Hanchar, H. J., Dodson, P. D., Olsen, R. W., Otis, T. S., & Wallner, M. (2005). Alcohol-induced motor impairment caused by increased extrasynaptic GABAA receptor activity. Nature Neuroscience, 8, 339-345. https://doi.org/10.1038/nn1398
Hartiadi, L. Y., Ahring, P. K., Chebib, M., & Absalom, N. L. (2016). High and low GABA sensitivity α4β2δ GABAA receptors are expressed in Xenopus laevis oocytes with divergent stoichiometries. Biochemical Pharmacology, 103, 98-108. https://doi.org/10.1016/j.bcp.2015.12.021
Iura, A., Takahashi, A., Hakata, S., Mashimo, T., & Fujino, Y. (2016). Reductions in tonic GABAergic current in substantia gelatinosa neurons and GABAA receptor δ subunit expression after chronic constriction injury of the sciatic nerve in mice. European Journal of Pain (United Kingdom), 20, 1678-1688.
Jensen, M. L., Wafford, K. A., Brown, A. R., Belelli, D., Lambert, J. J., & Mirza, N. R. (2013). A study of subunit selectivity, mechanism and site of action of the delta selective compound 2 (DS2) at human recombinant and rodent native GABAA receptors. British Journal of Pharmacology, 168, 1118-1132. https://doi.org/10.1111/bph.12001
Karim, N., Wellendorph, P., Absalom, N., Bang, L. H., Jensen, M. L., Hansen, M. M., Lee, H. J., Johnston, G. A. R., Hanrahan, J. R., & Chebib, M. (2012). Low nanomolar GABA effects at extrasynaptic α4β1/β3δ GABAA receptor subtypes indicate a different binding mode for GABA at these receptors. Biochemical Pharmacology, 84, 549-557. https://doi.org/10.1016/j.bcp.2012.05.017
Kaur, K. H., Baur, R., & Sigel, E. (2009). Unanticipated structural and functional properties of δ-subunit-containing GABAA receptors. The Journal of Biological Chemistry, 284, 7889-7896. https://doi.org/10.1074/jbc.M806484200
Keramidas, A., & Harrison, N. L. (2008). Agonist-dependent single channel current and gating in α4β2δ and α1β2γ2S GABAA receptors. The Journal of General Physiology, 131, 163-181. https://doi.org/10.1085/jgp.200709871
Kowal, N. M., Ahring, P. K., Liao, V. W. Y., Indurti, D. C., Harvey, B. S., O'Connor, S. M., Chebib, M., Olafsdottir, E. S., & Balle, T. (2018). Galantamine is not a positive allosteric modulator of human α4β2 or α7 nicotinic acetylcholine receptors. British Journal of Pharmacology, 175, 2911-2925. https://doi.org/10.1111/bph.14329
Lee, H. J., Absalom, N. L., Hanrahan, J. R., Van Nieuwenhuijzen, P., Ahring, P. K., & Chebib, M. (2016). A pharmacological characterization of GABA, THIP and DS2 at binary α4β3 and β3δ receptors: GABA activates β3δ receptors via the β3(+)δ(−) interface. Brain Research, 1644, 222-230. https://doi.org/10.1016/j.brainres.2016.05.019
L'Estrade, E. T., Hansen, H. D., Falk-Petersen, C., Haugaard, A., Griem-Krey, N., Jung, S., Lüddens, H., Schirmeister, T., Erlandsson, M., Ohlsson, T., Knudsen, G. M., Herth, M. M., Wellendorph, P., & Frølund, B. (2019). Synthesis and pharmacological evaluation of [11C]4-methoxy-N-[2-(thiophen-2-yl)imidazo[1,2-a]pyridin-3-yl]benzamide as a brain penetrant PET ligand selective for the δ-subunit-containing γ-aminobutyric acid type A receptors. ACS Omega, 4, 8846-8851. https://doi.org/10.1021/acsomega.9b00434
Liao, V. W. Y., Chua, H. C., Kowal, N. M., Chebib, M., Balle, T., & Ahring, P. K. (2019). Concatenated γ-aminobutyric acid type A receptors revisited: Finding order in chaos. The Journal of General Physiology, 151, 798-819. https://doi.org/10.1085/jgp.201812133
Liao, V. W. Y., Kusay, A. S., Balle, T., & Ahring, P. K. (2020). Heterologous expression of concatenated nicotinic ACh receptors: Pros and cons of subunit concatenation and recommendations for construct designs. British Journal of Pharmacology, 177, 4275-4295. https://doi.org/10.1111/bph.15188
Maldonado-Avilés, J. G., Curley, A. A., Hashimoto, T., Morrow, A. L., Ramsey, A. J., O'Donnell, P., Volk, D. W., & Lewis, D. A. (2009). Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia. The American Journal of Psychiatry, 166, 450-459. https://doi.org/10.1176/appi.ajp.2008.08101484
Milenkovic, I., Vasiljevic, M., Maurer, D., Hoger, H., Klausberger, T., & Sieghart, W. (2013). The parvalbumin-positive interneurons in the mouse dentate gyrus express GABAA receptor subunits alpha1, beta2, and delta along their extrasynaptic cell membrane. Neuroscience, 254, 80-96. https://doi.org/10.1016/j.neuroscience.2013.09.019
Mirza, N. D., Larsen, J. S., Mathiasen, C., Jacobsen, T. A., Munro, G., Erichsen, H. K., Nielsen, A. N., Troelsen, K. B., Nielsen, E. Ø., & Ahring, P. K. (2008). NS11394 [3′-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: In vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy. The Journal of Pharmacology and Experimental Therapeutics, 327, 954-968. https://doi.org/10.1124/jpet.108.138859
Shen, H., Gong, Q. H., Aoki, C., Yuan, M., Ruderman, Y., Dattilo, M., Williams, K., & Smith, S. S. (2007). Reversal of neurosteroid effects at α4β2δ GABAA receptors triggers anxiety at puberty. Nature Neuroscience, 10, 469-477. https://doi.org/10.1038/nn1868
Shen, H., Sabaliauskas, N., Sherpa, A., Fenton, A. A., Stelzer, A., Aoki, C., & Smith, S. S. (2010). A critical role for α4βδ GABAA receptors in shaping learning deficits at puberty in mice. Science, 327(80), 1515-1518.
Shu, H. J., Bracamontes, J., Taylor, A., Wu, K., Eaton, M. M., Akk, G., Manion, B., Evers, A. S., Krishnan, K., Covey, D. F., Zorumski, C. F., Steinbach, J. H., & Mennerick, S. (2012). Characteristics of concatemeric GABAA receptors containing α4/δ subunits expressed in Xenopus oocytes. British Journal of Pharmacology, 165, 2228-2243. https://doi.org/10.1111/j.1476-5381.2011.01690.x
Sigel, E., Kaur, K. H., Luscher, B. P., & Baur, R. (2009). Use of concatamers to study GABAA receptor architecture and function: Application to δ-subunit-containing receptors and possible pitfalls. Biochemical Society Transactions, 37, 1338-1342. https://doi.org/10.1042/BST0371338
Smith, S. S., Shen, H., Gong, Q. H., & Zhou, X. (2007). Neurosteroid regulation of GABAA receptors: Focus on the α4 and δ subunits. Pharmacology & Therapeutics, 116, 58-76. https://doi.org/10.1016/j.pharmthera.2007.03.008
Stórustovu, S. Í., & Ebert, B. (2006). Pharmacological characterization of agonists at δ-containing GABAA receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of γ2. The Journal of Pharmacology and Experimental Therapeutics, 316, 1351-1359. https://doi.org/10.1124/jpet.105.092403
Sundstrom-Poromaa, I., Smith, D. H., Gong, Q. H., Sabado, T. N., Li, X., Light, A., Wiedmann, M., Williams, K., & Smith, S. S. (2002). Hormonally regulated α4β2δ GABAA receptors are a target for alcohol. Nature Neuroscience, 5, 721-722. https://doi.org/10.1038/nn888
Wafford, K. A., van Niel, M. B., Ma, Q. P., Horridge, E., Herd, M. B., Peden, D. R., Belellic, D., & Lambert, J. J. (2009). Novel compounds selectively enhance δ subunit containing GABAA receptors and increase tonic currents in thalamus. Neuropharmacology, 56, 182-189. https://doi.org/10.1016/j.neuropharm.2008.08.004
Wallner, M., Hanchar, H. J., & Olsen, R. W. (2003). Ethanol enhances α4β3δ and α6β3δ γ-aminobutyric acid type A receptors at low concentrations known to affect humans. Proceedings of the National Academy of Sciences of the United States of America, 100, 15218-15223. https://doi.org/10.1073/pnas.2435171100
Whissell, P. D., Lecker, I., Wang, D.-S., Yu, J., & Orser, B. A. (2015). Altered expression of δ GABAA receptors in health and disease. Neuropharmacology, 88, 24-35. https://doi.org/10.1016/j.neuropharm.2014.08.003
Whissell, P. D., Rosenzweig, S., Lecker, I., Wang, D. S., Wojtowicz, J. M., & Orser, B. A. (2013). γ-Aminobutyric acid type A receptors that contain the δ subunit promote memory and neurogenesis in the dentate gyrus. Annals of Neurology, 74, 611-621. https://doi.org/10.1002/ana.23941
Wohlfarth, K. M., Bianchi, M. T., & Macdonald, R. L. (2002). Enhanced neurosteroid potentiation of ternary GABAA receptors containing the δ subunit. The Journal of Neuroscience, 22, 1541-1549. https://doi.org/10.1523/JNEUROSCI.22-05-01541.2002
Wongsamitkul, N., Baur, R., & Sigel, E. (2016). Toward understanding functional properties and subunit arrangement of α4β2δ γ-aminobutyric acid, type A (GABAA) receptors. The Journal of Biological Chemistry, 291, 18474-18483. https://doi.org/10.1074/jbc.M116.738906
Yamashita, M., Marszalec, W., Yeh, J. Z., & Narahashi, T. (2006). Effects of ethanol on tonic GABA currents in cerebellar granule cells and mammalian cells recombinantly expressing GABAA receptors. The Journal of Pharmacology and Experimental Therapeutics, 319, 431-438. https://doi.org/10.1124/jpet.106.106260
Zheleznova, N., Sedelnikova, A., & Weiss, D. S. (2008). α1β2δ, a silent GABAA receptor: Recruitment by tracazolate and neurosteroids. British Journal of Pharmacology, 153, 1062-1071. https://doi.org/10.1038/sj.bjp.0707665
Zheleznova, N. N., Sedelnikova, A., & Weiss, D. S. (2009). Function and modulation of δ-containing GABAA receptors. Psychoneuroendocrinology, 34, 4-10.
Zhu, S., Noviello, C. M., Teng, J., Walsh, R. M., Kim, J. J., & Hibbs, R. E. (2018). Structure of a human synaptic GABAA receptor. Nature, 559, 67-88. https://doi.org/10.1038/s41586-018-0255-3